David Kavanagh Consultant Nephrologist Newcastle

David Kavanagh Consultant Nephrologist Newcastle – Leader in Complement Therapeutics

David Kavanagh Consultant Nephrologist Newcastle is a leading expert in complement-mediated renal diseases. He serves as Professor of Complement Therapeutics at Newcastle University. In addition, he is an Honorary Consultant Nephrologist at the Freeman Hospital’s Renal Services Centre. His work bridges academic research, patient care, and innovative treatment models.

National Renal Complement Therapeutics Centre – Advancing Renal Care

David Kavanagh leads the National Renal Complement Therapeutics Centre (NRCTC). The NRCTC combines clinical diagnostics, treatment, and research into one integrated facility. It specializes in atypical haemolytic uraemic syndrome (aHUS) and C3 glomerulopathy (C3G). These are rare, complement-related kidney diseases requiring advanced care.

After a competitive process in 2016, NHS England selected the NRCTC to manage national aHUS and C3G services. Since then, the centre has delivered fully integrated care pathways. It works closely with referring clinicians to offer shared-care treatment models. Because of this approach, patients experience faster and more accurate treatment plans.

David Kavanagh Consultant Nephrologist Newcastle – Driving Innovation and Research

The NRCTC’s work in healthcare delivery earned it the 2017 Bright Ideas in Health Award. This recognition reflects the team’s dedication to improving patient outcomes. Clinical trials and research are central to the NRCTC’s mission. Those interested in current studies can find details on the NRCTC website.

Professor Kavanagh’s clinical interests include:

• Atypical Haemolytic Uraemic Syndrome (aHUS)

• C3 Glomerulopathy (C3G)

• Complement-related renal disease

• Retinal Vasculopathy with Cerebral Leucodystrophy (RVCL)

• Glomerulonephritis and vasculitis

• Age-related Macular Degeneration (AMD)

Newcastle University and Translational Research

In 2008, David Kavanagh Consultant Nephrologist Newcastle started his research lab at Newcastle University. His work continues to focus on complement biology in renal and retinal diseases. Previously, he was a Fellow at the University of Edinburgh and at Washington University School of Medicine in St. Louis.

He earned his medical degree and an Immunology degree from the University of Glasgow in 1998. His PhD, obtained from Newcastle in 2006, focused on the complement system in aHUS. His research earned him the Renal Association’s Young Investigator (Raine) Award.

Kavanagh’s lab is integrated with the NRCTC, allowing his discoveries to benefit patients quickly. He is also an academic founder of Gyroscope Therapeutics. This biotech company pioneered the use of gene therapy for AMD.

Clinical Leadership and Global Recognition

In addition to his research, Professor Kavanagh runs a glomerulonephritis and vasculitis clinic at the Freeman Hospital. His leadership, both clinical and academic, continues to impact patients across the UK. Through partnerships and innovation, he helps shape the future of nephrology care.